Clondalkin invests €1m to enhance packaging pharma, healthcare business
Clondalkin, a provider of packaging products and services, has invested €1m in labels market to enhance its specialist packaging pharma and healthcare business.
As a part of the investment, Gallus ECS 340 press was installed at Clondalkin Pharma & Healthcare Kimbolton to expand the quality and efficient label production capabilities.
The nine colour UV press features 340mm wide print, cold foil and reverse print capabilities, according to the company.
Additionally, the company completed upgrades to two existing presses at Clondalkin Pharma & Healthcare Hull.
A Gallus EM 260 flexo press has been upgraded with a new re-register unit and two additional print heads for label production in nine colours and up to four layers.
MPS flexo press is upgraded with an additional print head taking it up to 10 colours and a new web shifting unit allowing production of a five ply label in a single pass.
Clondalkin specialist packaging division European sales director Malcolm Farnan said the investment creates two distinctive but complementary site offerings.
"Hull has a strong reputation for quality and innovation in the multi ply label sector which is highly valued by European brand owners and these significant upgrades strengthen this proposition," Farnan added.
"Kimbolton is now fully equipped to service the single ply pharma, cosmetics and toiletries market. We are very excited by these investments which significantly enhance our product and service capabilities and we are very pleased with customer interest in these service innovations."